Global Atorvastatin Calcium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Atorvastatin Calcium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade nameLipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin Calcium report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atorvastatin Calcium market is projected to reach US$ 365.5 million in 2034, increasing from US$ 219 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Tablet (Including Dispersible Tablet and General Tablet) and Capsule are the major drivers for the industry.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atorvastatin Calcium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Segment by Type
Chemical Synthesis
Biocatalysis
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Atorvastatin Calcium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atorvastatin Calcium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atorvastatin Calcium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atorvastatin Calcium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atorvastatin Calcium introduction, etc. Atorvastatin Calcium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Atorvastatin Calcium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Atorvastatin Calcium report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atorvastatin Calcium market is projected to reach US$ 365.5 million in 2034, increasing from US$ 219 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Tablet (Including Dispersible Tablet and General Tablet) and Capsule are the major drivers for the industry.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atorvastatin Calcium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Segment by Type
Chemical Synthesis
Biocatalysis
Segment by Application
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Atorvastatin Calcium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atorvastatin Calcium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atorvastatin Calcium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atorvastatin Calcium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atorvastatin Calcium introduction, etc. Atorvastatin Calcium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Atorvastatin Calcium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices